Recent News

FDA Grants Madorra Breakthrough Device Designation Status for Treatment of Moderate to Severe Vulvovaginal Atrophy

2021-09-08

Image-empty-state_edited.png

Hawthorne Effect Completes $20 Million Series A Round of Financing to Decentralize Clinical Trials

2021-06-09

Image-empty-state_edited.png

Organon Launches as New Global Women’s Health Company

2021-06-03

Image-empty-state_edited.png

Zenflow Announces $24 Million Financing Round; Appoints Susan Stimson as President

2021-06-02

Image-empty-state_edited.png

Terviva Closes $54M in Financing to Commercialize Sustainable Food Ingredients, Launches Collaboration with Danone

2021-05-20

Image-empty-state_edited.png

Bone Health Technologies Raises $2.5M In New Funding Round, Adds 3 Members To Board

2021-05-03

Image-empty-state_edited.png

Astia Portfolio Company Alydia Health Acquired by Merck

2021-03-30

KENILWORTH, N.J. & MENLO PARK, Calif.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Alydia Health announced today that they have entered into a definitive agreement pursuant to which, after the intended Merck spinoff of Organon, Organon will acquire Alydia Health. Alydia Health is a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding. PPH is one of the most common complications of birth, resulting in pharmacologic treatment in up to 10% of mothers and potentially resulting in emergency intervention such as hysterectomy and blood transfusions, and, in some cases, maternal death.1 The transaction is expected to close after Organon has spun off from Merck as a standalone publicly traded company.

Image-empty-state_edited.png

Sharon Vosmek included in UKTN's "The most powerful female VCs in UK tech"

2021-03-04

Sharon Vosmek included in UKTN's "The most powerful female VCs in UK tech": https://www.uktech.news/women-in-tech/the-most-powerful-female-vcs-in-uk-tech-20210304

Image-empty-state_edited.png

Astia Managing Director Angela Holter and Astia Fund featured in Shifter Norway

2021-03-01

Norway-based Astia Managing Director Angela Holter talks about Astia's thesis and our Astia Fund in a recent piece in Shift Norway.

Image-empty-state_edited.png

Astia Fund selected to the ImpactAssets 50 2021

2021-02-23

Astia is excited to announce that Astia Fund has been selected to the ImpactAssets 50 2021! The #IA50 recognizes a diverse group of impact investment fund managers who demonstrate a commitment to generating positive social, environmental and financial impact.

Image-empty-state_edited.png

Podcasts